Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 10, 2007Current Opinion in Neurology

Treatment and treatment trials in multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBernd C. KieseierNovartis (Switzerland)HWHeinz WiendlUniversity of FreiburgBHBernhard HemmerBroad Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kieseier et al. (2007) studied this question.

synapsesocial.com/papers/6a950b37c05e7b5813b2d149https://doi.org/10.1097/wco.0b013e3281568b80
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple Sclerosis2005 · 212 citations
  2. 2No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment2002 · 83 citations
  3. 3Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses1998 · 260 citations
  4. 4Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”2001 · 245 citations